Safety profiles and efficacy of infliximab therapy in Japanese patients with plaque psoriasis with or without psoriatic arthritis, pustular psoriasis or psoriatic erythroderma: Results from the prospective post-marketing surveillance

Tolerability and Safety of Biological Therapies for Psoriasis in Daily Clinical Practice: A Study of 103 Italian Patients

(2016) A Brunasso et al.   ACTA DERMATO-VENEREOLOGICA

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

(2014) Sofia Ramiro et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practice

(2014) N.H. Shear et al.   BRITISH JOURNAL OF DERMATOLOGY

Patient reports of the frequency and severity of adverse reactions associated with biological agents prescribed for psoriasis in Brazil

(2014) Luciane Cruz Lopes et al.   Expert Opinion On Drug Safety

Cancer Incidence and Incidence Rates in Japan in 2008: A Study of 25 Population-based Cancer Registries for the Monitoring of Cancer Incidence in Japan (MCIJ) Project

(2014) A. Matsuda et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis

(2014) Takao Koike et al.   Modern Rheumatology

Infliximab in Psoriasis and Psoriatic Arthritis

(2013) Marina Papoutsaki et al.   BIODRUGS

Japanese guidance for use of biologics for psoriasis (the 2013 version)

(2013) Mamitaro Ohtsuki et al.   JOURNAL OF DERMATOLOGY

Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions

(2013) J. Spertino et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients

(2013) Takao Koike et al.   Modern Rheumatology

Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study

(2012) M. Viguier et al.   BRITISH JOURNAL OF DERMATOLOGY

Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris

(2011) R. Gniadecki et al.   BRITISH JOURNAL OF DERMATOLOGY

Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies

(2010) Fernando Magro et al.   BIODRUGS

Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial

(2010) Hideshi Torii et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Long-term study of infliximab in Japanese patients with plaque psoriasis, psoriatic arthritis, pustular psoriasis and psoriatic erythroderma

(2010) Hideshi TORII et al.   JOURNAL OF DERMATOLOGY

Pneumocystis jirovecipneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case-control study of 21 patients

(2009) Yukiko Komano et al.   ARTHRITIS AND RHEUMATISM